Neuroprotective effects of verbascoside against Alzheimer's disease via the relief of endoplasmic reticulum stress in Aβ-exposed U251 cells and APP/PS1 mice.

Abstract

BACKGROUND:

Endoplasmic reticulum (ER) stress is involved in the progression of Alzheimer's disease (AD). Verbascoside (VB), an active phenylethanoid glycoside that was first isolated from Verbascum sinuatum (the wavyleaf mullein), possesses anti-inflammatory, antioxidative, and anti-apoptotic effects. The purpose of this study was to elucidate the beneficial effects of VB in amyloid β (Aβ)1-42-damaged human glioma (U251) cells and in APPswe/PSEN1dE9 transgenic (APP/PS1) mice.

METHODS:

U251 cells were co-incubated with 10 μM of Aβ1-42 and treated with VB. The protective effects of VB were investigated by using 3-(4,5-dimethylthiazole-2-yl)-2,5-diphenyl tetrazolium bromide assay, flow cytometry, fluorescence staining, and transmission electron microscopy. APP/PS1 transgenic mice were treated for 6 weeks with VB. Learning and memory were evaluated using a Morris water maze test. Immunohistochemistry, terminal deoxynucleotidyl transferase-mediated deoxyuridine triphosphate nick end labeling, thioflavin-S staining, and proteomics analysis were performed to study the potential neuroprotective mechanism. Enzyme-linked immunosorbent assays and western blot were performed to analyze altered protein levels of brain lysates in APP/PS1 mice and/or Aβ1-42-damaged U251 cells.

RESULTS:

In Aβ1-42-damaged U251 cells, VB significantly improved cell viability, inhibited apoptosis, reduced calcium accumulation and the intracellular concentrations of reactive oxygen species, and improved the morphology of mitochondria and ER. In APP/PS1 mice, 6-week administration of VB significantly improved memory and cognition. VB inhibited apoptosis, reduced the deposition of Aβ, reduced the formation of neurofibrillary tangles formed by hyperphosphorylated tau protein, and downregulated the expression levels of 4-hydroxynonenal and mesencephalic astrocyte-derived neurotrophic factor in the brains of APP/PS1 mice. Proteomics analysis of mouse hippocampus suggested that the neuroprotective effect of VB may be related to the reduction of ER stress. This was indicated by the fact that VB inhibited the three branches of the unfolded protein response, thereby attenuating ER stress and preventing apoptosis.

CONCLUSIONS:

The results confirmed that VB possesses significant neuroprotective effects, which are related to the reduction of ER stress. These findings support the status of VB as a potentially effective treatment for AD and warrant further research.

• Authors: Chunyue Wang, Xueying Cai, Ruochen Wang, Siyu Zhai, Yongfeng Zhang, Wenji Hu, Yizhi Zhang, Di Wang
• Journal: Journal of neuroinflammation (J Neuroinflammation) Vol. 17 Issue 1 Pg. 309 (Oct 18 2020) ISSN: 1742-2094 [Electronic] England
• PMID: 33070776 (Publication Type: Journal Article)

Chemical References

• Amyloid beta-Peptides
• Amyloid beta-Protein Precursor
• Glucosides
• Immunosuppressive Agents
• Neuroprotective Agents
• Peptide Fragments
• Phenols
• Presenilin-1
• amyloid beta-protein (1-42)
• acteoside

Topics

• Alzheimer Disease (chemically induced, genetics, metabolism, prevention & control)
• Amyloid beta-Peptides (toxicity)
• Amyloid beta-Protein Precursor (genetics)
• Animals
• Cell Line
• Cell Survival (drug effects, physiology)
• Dose-Response Relationship, Drug
• Endoplasmic Reticulum Stress (drug effects, physiology)
• Glucosides (pharmacology, therapeutic use)
• Immunosuppressive Agents (pharmacology, therapeutic use)
• Male
• Mice
• Mice, Transgenic
• Neuroprotective Agents (pharmacology, therapeutic use)
• Peptide Fragments (toxicity)
• Phenols (pharmacology, therapeutic use)
• Presenilin-1 (genetics)